The baseline characteristics of both groups are detailed in Table 1, with chi-square analysis indicating a significant correlation between CHORDC1 expression and Ki-67 levels in ER+ breast cancer patients (P = 0.02). This evidence concerns the gene CHORDC1 and breast cancer.